Healthcare News
27/11/2009
Ghrelin can boost a person's resistance to Parkinson's disease, it has been discovered.
The importance of dopamine in regards to Parkinson's disease has been addressed by researchers in the US.
It is a widely-held understanding that the degeneration of dopamine neurons in an area of the brain known as the substantia nigra - which is responsible for dopamine production - leads to a worsening of conditions.
This can lead to an increased difficulty in walking, restricted movements, a lack of appetite, periods of motionlessness and notable head and limb tremors, according to scientists on the project at the Yale School of Medicine.
Tamas Horvath, the chair of the facility and professor of comparative medicine, explained that he and his team discovered that ghrelin is responsible for directly activating the brain's dopamine calls.
He continued: "Because this hormone originates from the stomach, it is circulating normally in the body, so it could easily be used to boost resistance to Parkinson's or it could be used to slow the development of the disease."
Earlier this month, it was discovered that red tomatoes contain a lot of ghrelin, as well as making a person feel fuller quicker.
Please click here for advice to help you find the right type of care.
Hollyoaks star aims to attract support to Parkinson's marathon support
03/02/2010
A former Hollyoaks actor is pledging his support to the Parkinson's Disease Society (PDS).
Calcium-based heart drugs 'could reduce heart risks'
02/02/2010
People taking a certain heart drug could reduce their risk of Parkinson's disease, it is asserted.
Parkinson's disease clues 'could be held in mice'
22/01/2010
The PDS has funded progressive research into the advancement of Parkinson's disease in mice models.
Parkinson's genetic risk factor discovered
18/01/2010
A genetic risk factor for Parkinson's disease has been identified by a new study.